Cancer cytogenetics is a valuable tool for the analysis of cellular an
d molecular aberrations during malignant transformation and tumor prog
ression. The rat has served as an important experimental model to inve
stigate various steps in oncogenesis. An attempt was made to compile d
ata on rat tumor cytogenetics from previously published data in order
to provide a basis for further research, especially when combining cla
ssic and molecular cytogenetics, a yet underdeveloped area of research
in rat tumorigenesis. The wealth of data presented here provides a co
ntrast to its impact on biological specificity. Because of the differe
nt experimental procedures involved with tumor induction and the appli
cation of carcinogens at relatively high dosages, as well as occasiona
l less than careful histological documentation, a delineation of unamb
iguous chromosome alterations, critical in the process of carcinogenes
is, is rare in the rat. Future studies should be performed with sponta
neously arising rat tumors and/or tumors after low, single-dose carcin
ogen exposure in order to reduce unspecific karyotype alterations not
intrinsically related to tumor initiation and progression. Short-term
culture or early passages in vitro should be methods of choice, especi
ally for solid tumors, to avoid erroneous karyotype analyses because o
f contaminating normal cells. The combined karyological and molecular
genetic approach to an analysis of tumor-specific changes, still hinde
red by an almost complete lack of cell type-, chromosome-, or gene-spe
cific molecular probes for the rat, should become a focus of research
in order to continue having the advantages this species offers for sta
ge-specific analysis of tumorigenesis.